Avanos Medical (AVNS) Accumulated Expenses (2013 - 2026)

Avanos Medical (AVNS) has 14 years of Accumulated Expenses data on file, last reported at $57.6 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Expenses fell 19.33% year-over-year to $57.6 million; the trailing twelve-month figure through Mar 2026 stood at $57.6 million (down 19.33% YoY), and the FY2025 full-year result was $91.3 million, changed 0.0% from the prior year.
• Accumulated Expenses slipped to $57.6 million in Q1 2026, from $91.3 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $97.8 million in Q4 2022 to a low of $57.6 million in Q1 2026.
• A 5-year average of $79.7 million and a median of $79.5 million in 2024 frame the typical range for Accumulated Expenses.
• Across the five-year window, Accumulated Expenses jumped 43.61% in 2022 and declined 19.33% in 2026, its largest moves.
• Tracing AVNS's Accumulated Expenses over 5 years: stood at $97.8 million in 2022, then decreased by 4.7% to $93.2 million in 2023, then decreased by 2.04% to $91.3 million in 2024, then changed by 0.0% to $91.3 million in 2025, then tumbled by 36.91% to $57.6 million in 2026.
• Business Quant data shows AVNS's Accumulated Expenses at $57.6 million in Q1 2026, $91.3 million in Q4 2025, and $74.8 million in Q3 2025.